Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Palisade Bio (PALI) Restructuring Costs (2024 - 2025)

Historic Restructuring Costs for Palisade Bio (PALI) over the last 3 years, with Q3 2025 value amounting to $1.5 million.

  • Palisade Bio's Restructuring Costs rose 2240.13% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.4 million, marking a year-over-year increase of 3170.14%. This contributed to the annual value of $5.5 million for FY2024, which is 973.8% down from last year.
  • As of Q3 2025, Palisade Bio's Restructuring Costs stood at $1.5 million, which was up 2240.13% from $1.1 million recorded in Q2 2025.
  • In the past 5 years, Palisade Bio's Restructuring Costs ranged from a high of $1.5 million in Q3 2025 and a low of $1.1 million during Q2 2025